Cargando…
Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series
BACKGROUND: A novel antiviral agent, remdesivir (RDV), is a promising candidate treatment for coronavirus disease 2019 (COVID-19) in the absence of any proven therapy. MATERIALS AND METHODS: This retrospective case series included 10 patients with a clinically and laboratory confirmed diagnosis of s...
Autores principales: | Lee, Choongman, Ahn, Mi Young, Byeon, Kyeongmin, Choi, Jae-Phil, Hahm, Chorom, Kim, Hyeonmok, Kim, Suhyun, Kim, Tae Ho, Oh, JungKyun, Oh, Dong Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533211/ https://www.ncbi.nlm.nih.gov/pubmed/32757500 http://dx.doi.org/10.3947/ic.2020.52.3.369 |
Ejemplares similares
-
Factors Associated with Worsening Oxygenation in Patients with Non-severe COVID-19 Pneumonia
por: Hahm, Cho Rom, et al.
Publicado: (2021) -
Pneumonia-targeted lopinavir/ritonavir-based treatment for patients with COVID-19: an early-period retrospective single center observational study
por: Kim, Jongkyu, et al.
Publicado: (2021) -
Four cases of coronavirus disease 2019 in the early stage of pandemic of South Korea: a single public hospital experience
por: Ahn, Mi Young, et al.
Publicado: (2020) -
Remdesivir in Pregnant Patients with Novel Coronavirus Disease 2019: Case Series
por: Singh, Renu, et al.
Publicado: (2021) -
Changes in the glucose and insulin responses according to high-protein snacks for diabetic patients
por: Yang, Junyoung, et al.
Publicado: (2021)